IRIX (IRIDEX) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 03, 2026)


IRIX IRIDEX Corp IRIX
58 GF Score
Price $1.13
GF Value $1.70
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is IRIDEX 5-Year Yield-on-Cost %?

IRIDEX IRIX -3.42% 58 5-Year Yield-on-Cost % is 0.00 as of Jul. 03, 2026. GuruFocus rates IRIX with a GF Score™ of 58/100 and a GF Value™ of $1.70 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 328 Medical Devices & Instruments companies, IRIDEX ranks worse than 304877.74% on this metric.

IRIDEX's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for IRIDEX's 5-Year Yield-on-Cost % or its related term are showing as below:



IRIX's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.325
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

IRIDEX  (NAS:IRIX) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


IRIDEX 5-Year Yield-on-Cost % Related Terms


IRIX vs ICCM, LFWD, GTHP: 5-Year Yield-on-Cost % Comparison

For the Medical Devices subindustry, IRIDEX's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IRIDEX 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IRIDEX's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where IRIDEX's 5-Year Yield-on-Cost % falls into.


IRIX
58GF Score
IRIDEX Corp IRIX
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IRIDEX 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of IRIDEX is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
IRIDEX (IRIX) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 03, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on IRIDEX and its competitors. According to the industry distribution chart, IRIDEX ranks #999999 out of 328 companies in the Medical Devices & Instruments industry.
Is IRIDEX's 5-Year Yield-on-Cost % too high?
IRIDEX's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, IRIDEX ranks #999999 out of 328 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, IRIDEX has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does IRIDEX's 5-Year Yield-on-Cost % compare to ICCM and LFWD?
According to the Medical Devices & Instruments industry distribution chart, IRIDEX ranks #999999 out of 328 companies for 5-Year Yield-on-Cost %. This places IRIDEX in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.33. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.33, based on 328 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on IRIDEX and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IRIDEX's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IRIDEX stock overvalued right now?
Based on GuruFocus' analysis, IRIDEX (IRIX) is currently considered Possible Value Trap. The stock's GF Value™ is $1.70, compared to a current price of $1.13 — trading 33.5% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. IRIDEX's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For IRIDEX (IRIX), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IRIDEX (IRIX) Overvalued in 2026?

Based on GuruFocus' analysis, IRIDEX stock appears to be undervalued. The current stock price of $1.13 is trading 33.5% below its estimated GF Value™ of $1.70. GuruFocus considers IRIDEX to be Possible Value Trap.

Key valuation signals for IRIX:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: $1.70 vs. price of $1.13 (33.5% below fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the IRIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IRIDEX Business Description

Address 1212 Terra Bella Avenue, Mountain View, CA, USA, 94043
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
58GF Score

Get the complete analysis for IRIX

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.13
Price
$1.70
GF Value